4
Changes in Ownership
BOSTON SCIENTIFIC CORP Filed Acc 0001225208-22-003295
Options or other derivatives
- EVP Global Chief Med Officer acquired 6,540 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Meredith Ian T · EVP Global Chief Med Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-22 | Grant or award : show line 1 in the form Performance Share Units | +6,540 | 2023-12-31 | 6,540 | 6,540 | D |
Loading xslF345X03/doc4.xml…